Pregled bibliografske jedinice broj: 1215043
Diplopia, COVID-19 and Vaccination: Results from a Cross-Sectional Study in Croatia
Diplopia, COVID-19 and Vaccination: Results from a Cross-Sectional Study in Croatia // Vaccine, 10 (2022), 9; 1558-1558 doi:10.3390/vaccines10091558 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1215043 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Diplopia, COVID-19 and Vaccination: Results from a
Cross-Sectional Study in Croatia
Autori
Škunca Herman, Jelena ; Marić, Goran ; Malenica Ravlić, Maja ; Knežević, Lana ; Jerković, Ivan ; Sušić, Ena ; Marić, Vedrana ; Petric Vicković, Ivanka ; Vatavuk, Zoran ; Polašek, Ozren
Izvornik
Vaccine (0264-410X) 10
(2022), 9;
1558-1558
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
vaccine ; COVID ; side-effect
Sažetak
The aim of this study was to explore diplopia as a symptom of undetected COVID-19 infection or as a possible side effect of COVID-19 vaccination. We examined 380 patients with diplopia admitted to the Department of Ophthalmology of the University Hospital Centre Sestre milosrdnice in Zagreb, Croatia, from July 2020 to June 2022. After excluding patients with confirmed organic underlying diplopia causes or monocular diplopia, we linked the patient information with the national COVID-19 and vaccination registries. Among the 91 patients included in this study, previously undetected COVID-19 infection as the possible cause of diplopia was confirmed in five of them (5.5%). An additional nine patients (9.9%) were vaccinated within one month from the onset of their symptoms, while the remaining 77 had neither and were therefore considered as controls. The breakdown according to the mechanism of diplopia showed no substantial difference between the vaccinated patients and the controls. We detected marginally insignificant excess abducens nerve affection in the COVID-positive group compared with that in the controls (p = 0.051). Post- vaccination diplopia was equally common in patients who received vector-based or RNA-based vaccines (21.4 vs. 16.7% ; p = 0.694). COVID-19 testing should be performed for all cases of otherwise unexplained diplopia. The risk of post- vaccination diplopia was similar in both types of vaccines administered, suggesting a lack of evidence linking specific vaccine types to diplopia.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
EK-EFRR-KK.01.2.2.03.0006 - Centar kompetencija u molekularnoj dijagnostici (CEKOM) (Knjaz, Damir; Lauc, Gordan; Vugrek, Oliver; Polašek, Ozren, EK - KK.01.2.2.03) ( CroRIS)
EK-KF-KK.01.1.1.01.0010 - Znanstveni centar izvrsnosti za personaliziranu brigu o zdravlju (ZCIPersonHealth) (Polašek, Ozren; Secenji, Aleksandar, EK ) ( CroRIS)
Ustanove:
Stomatološki fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Medicinski fakultet, Split,
Visoko učilište Algebra, Zagreb
Profili:
Zoran Vatavuk
(autor)
Ozren Polašek
(autor)
Jelena Škunca Herman
(autor)
Goran Marić
(autor)
Ivanka Petric Vicković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE